Part 1 TPST-1120
TPST-1120-001
Phase 1 small_molecule completed
Quick answer
Part 1 TPST-1120 for Hepatocellular Carcinoma is a Phase 1 program (small_molecule) at Tempest Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tempest Therapeutics
- Indication
- Hepatocellular Carcinoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed